f. peyvandi Et Al. , "EFFICACY AND SAFETY OF RURIOCTOCOG ALFA PEGOL IN PERIOPERATIVE MANAGEMENT: INTERIM RESULTS FROM AN OPEN-LABEL MULTICENTER CLINICAL TRIAL IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A," ısth congress , vol.28, Toronto, Canada, pp.48, 2022
peyvandi, f. Et Al. 2022. EFFICACY AND SAFETY OF RURIOCTOCOG ALFA PEGOL IN PERIOPERATIVE MANAGEMENT: INTERIM RESULTS FROM AN OPEN-LABEL MULTICENTER CLINICAL TRIAL IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A. ısth congress , (Toronto, Canada), 48.
peyvandi, f., Sidonio Jr, R., Stasyshyn, O., Glosli, H., Alamelu, J., Le, P., ... ALBAYRAK, C.(2022). EFFICACY AND SAFETY OF RURIOCTOCOG ALFA PEGOL IN PERIOPERATIVE MANAGEMENT: INTERIM RESULTS FROM AN OPEN-LABEL MULTICENTER CLINICAL TRIAL IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A . ısth congress (pp.48). Toronto, Canada
peyvandi, flora Et Al. "EFFICACY AND SAFETY OF RURIOCTOCOG ALFA PEGOL IN PERIOPERATIVE MANAGEMENT: INTERIM RESULTS FROM AN OPEN-LABEL MULTICENTER CLINICAL TRIAL IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A," ısth congress, Toronto, Canada, 2022
peyvandi, flora Et Al. "EFFICACY AND SAFETY OF RURIOCTOCOG ALFA PEGOL IN PERIOPERATIVE MANAGEMENT: INTERIM RESULTS FROM AN OPEN-LABEL MULTICENTER CLINICAL TRIAL IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A." ısth congress , Toronto, Canada, pp.48, 2022
peyvandi, f. Et Al. (2022) . "EFFICACY AND SAFETY OF RURIOCTOCOG ALFA PEGOL IN PERIOPERATIVE MANAGEMENT: INTERIM RESULTS FROM AN OPEN-LABEL MULTICENTER CLINICAL TRIAL IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A." ısth congress , Toronto, Canada, p.48.
@conferencepaper{conferencepaper, author={flora peyvandi Et Al. }, title={EFFICACY AND SAFETY OF RURIOCTOCOG ALFA PEGOL IN PERIOPERATIVE MANAGEMENT: INTERIM RESULTS FROM AN OPEN-LABEL MULTICENTER CLINICAL TRIAL IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A}, congress name={ısth congress}, city={Toronto}, country={Canada}, year={2022}, pages={48} }